ALPHYN BIOLOGICS

Lobbying client · Maryland · filed 2025 to 2026

Clinical-stage dermatology co. developing first-in-class Multi-Target Therapeutics (MTT)

$30,000 Reported spend

5 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page is grouped by the client's LDA id (69287), not by name.

Firms hired 1

SQUIRE PATTON BOGGS $30,000 5 filings

Reported by year 2 years

2026 $0 2 filings
2025 $30,000 3 filings

Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

Health & Human Services, Dept of (HHS) 1
SENATE 1

Recent filings 5 total

Q2Y

SQUIRE PATTON BOGGS

2nd Quarter (Apr 1 - June 30) 2026 · posted Jul 10, 2026

View → Q1Y

SQUIRE PATTON BOGGS

1st Quarter (Jan 1 - Mar 31) 2026 · posted Apr 14, 2026

View → Q4

SQUIRE PATTON BOGGS

4th Quarter (Oct 1 - Dec 31) 2025 · Senate · $30,000 income · posted Jan 13, 2026

View → Q3Y

SQUIRE PATTON BOGGS

3rd Quarter (July 1 - Sep 30) 2025 · posted Oct 18, 2025

View → RR

SQUIRE PATTON BOGGS

3rd Quarter (July 1 - Sep 30) 2025 · posted Oct 16, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.